Cargando…

Validation of the 12‐item World Health Organization Disability Assessment Schedule 2.0 in individuals with schizophrenia, depression, anxiety, and diabetes in Singapore

BACKGROUND: There is limited evidence on the reliability and validity of the 12-item World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) in an Asian patient population with mental and physical disorders. The current study aimed to examine the psychometric properties of the WHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdin, Edimansyah, Seet, Vanessa, Jeyagurunathan, Anitha, Tan, Sing Chik, Mok, Yee Ming, Verma, Swapna, Lee, Eng Sing, Subramaniam, Mythily
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688897/
https://www.ncbi.nlm.nih.gov/pubmed/38033104
http://dx.doi.org/10.1371/journal.pone.0294908
_version_ 1785152262987841536
author Abdin, Edimansyah
Seet, Vanessa
Jeyagurunathan, Anitha
Tan, Sing Chik
Mok, Yee Ming
Verma, Swapna
Lee, Eng Sing
Subramaniam, Mythily
author_facet Abdin, Edimansyah
Seet, Vanessa
Jeyagurunathan, Anitha
Tan, Sing Chik
Mok, Yee Ming
Verma, Swapna
Lee, Eng Sing
Subramaniam, Mythily
author_sort Abdin, Edimansyah
collection PubMed
description BACKGROUND: There is limited evidence on the reliability and validity of the 12-item World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) in an Asian patient population with mental and physical disorders. The current study aimed to examine the psychometric properties of the WHODAS 2.0 among patients with schizophrenia, depression, anxiety, and diabetes. METHODS: A total of 1076 patients (M  =  40.9 years, SD  =  14.7) were recruited from the outpatient clinics of a tertiary psychiatric hospital and a primary care clinic. Internal consistency and test-retest reliability, structural validity, convergent validity, agreement, and floor and ceiling effects were examined. RESULTS: Our confirmatory factor analysis (CFA) showed that the 1-factor model fits our data. Multigroup CFA demonstrated metric and scalar invariance, indicating the scores can be compared across the four conditions. The WHODAS 2.0 scale had excellent reliability in the overall sample and good to excellent reliability across conditions. The test-retest reliability and agreement between self-administered and interviewer-administered modes were good. The WHODAS 2.0 scores had moderate to strong correlations with the Social and Occupational Functioning Scale and the Sheehan Disability Scale scores in the overall sample and across four conditions. CONCLUSION: Findings suggest that the WHODAS 2.0 is a valid tool to measure functioning and disability in those with schizophrenia, anxiety, depression, and diabetes in an Asian patient population.
format Online
Article
Text
id pubmed-10688897
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-106888972023-12-01 Validation of the 12‐item World Health Organization Disability Assessment Schedule 2.0 in individuals with schizophrenia, depression, anxiety, and diabetes in Singapore Abdin, Edimansyah Seet, Vanessa Jeyagurunathan, Anitha Tan, Sing Chik Mok, Yee Ming Verma, Swapna Lee, Eng Sing Subramaniam, Mythily PLoS One Research Article BACKGROUND: There is limited evidence on the reliability and validity of the 12-item World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) in an Asian patient population with mental and physical disorders. The current study aimed to examine the psychometric properties of the WHODAS 2.0 among patients with schizophrenia, depression, anxiety, and diabetes. METHODS: A total of 1076 patients (M  =  40.9 years, SD  =  14.7) were recruited from the outpatient clinics of a tertiary psychiatric hospital and a primary care clinic. Internal consistency and test-retest reliability, structural validity, convergent validity, agreement, and floor and ceiling effects were examined. RESULTS: Our confirmatory factor analysis (CFA) showed that the 1-factor model fits our data. Multigroup CFA demonstrated metric and scalar invariance, indicating the scores can be compared across the four conditions. The WHODAS 2.0 scale had excellent reliability in the overall sample and good to excellent reliability across conditions. The test-retest reliability and agreement between self-administered and interviewer-administered modes were good. The WHODAS 2.0 scores had moderate to strong correlations with the Social and Occupational Functioning Scale and the Sheehan Disability Scale scores in the overall sample and across four conditions. CONCLUSION: Findings suggest that the WHODAS 2.0 is a valid tool to measure functioning and disability in those with schizophrenia, anxiety, depression, and diabetes in an Asian patient population. Public Library of Science 2023-11-30 /pmc/articles/PMC10688897/ /pubmed/38033104 http://dx.doi.org/10.1371/journal.pone.0294908 Text en © 2023 Abdin et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Abdin, Edimansyah
Seet, Vanessa
Jeyagurunathan, Anitha
Tan, Sing Chik
Mok, Yee Ming
Verma, Swapna
Lee, Eng Sing
Subramaniam, Mythily
Validation of the 12‐item World Health Organization Disability Assessment Schedule 2.0 in individuals with schizophrenia, depression, anxiety, and diabetes in Singapore
title Validation of the 12‐item World Health Organization Disability Assessment Schedule 2.0 in individuals with schizophrenia, depression, anxiety, and diabetes in Singapore
title_full Validation of the 12‐item World Health Organization Disability Assessment Schedule 2.0 in individuals with schizophrenia, depression, anxiety, and diabetes in Singapore
title_fullStr Validation of the 12‐item World Health Organization Disability Assessment Schedule 2.0 in individuals with schizophrenia, depression, anxiety, and diabetes in Singapore
title_full_unstemmed Validation of the 12‐item World Health Organization Disability Assessment Schedule 2.0 in individuals with schizophrenia, depression, anxiety, and diabetes in Singapore
title_short Validation of the 12‐item World Health Organization Disability Assessment Schedule 2.0 in individuals with schizophrenia, depression, anxiety, and diabetes in Singapore
title_sort validation of the 12‐item world health organization disability assessment schedule 2.0 in individuals with schizophrenia, depression, anxiety, and diabetes in singapore
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688897/
https://www.ncbi.nlm.nih.gov/pubmed/38033104
http://dx.doi.org/10.1371/journal.pone.0294908
work_keys_str_mv AT abdinedimansyah validationofthe12itemworldhealthorganizationdisabilityassessmentschedule20inindividualswithschizophreniadepressionanxietyanddiabetesinsingapore
AT seetvanessa validationofthe12itemworldhealthorganizationdisabilityassessmentschedule20inindividualswithschizophreniadepressionanxietyanddiabetesinsingapore
AT jeyagurunathananitha validationofthe12itemworldhealthorganizationdisabilityassessmentschedule20inindividualswithschizophreniadepressionanxietyanddiabetesinsingapore
AT tansingchik validationofthe12itemworldhealthorganizationdisabilityassessmentschedule20inindividualswithschizophreniadepressionanxietyanddiabetesinsingapore
AT mokyeeming validationofthe12itemworldhealthorganizationdisabilityassessmentschedule20inindividualswithschizophreniadepressionanxietyanddiabetesinsingapore
AT vermaswapna validationofthe12itemworldhealthorganizationdisabilityassessmentschedule20inindividualswithschizophreniadepressionanxietyanddiabetesinsingapore
AT leeengsing validationofthe12itemworldhealthorganizationdisabilityassessmentschedule20inindividualswithschizophreniadepressionanxietyanddiabetesinsingapore
AT subramaniammythily validationofthe12itemworldhealthorganizationdisabilityassessmentschedule20inindividualswithschizophreniadepressionanxietyanddiabetesinsingapore